<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04780243</url>
  </required_header>
  <id_info>
    <org_study_id>abe16muluneh</org_study_id>
    <nct_id>NCT04780243</nct_id>
  </id_info>
  <brief_title>Expanded Program for Immunization, a Missed Opportunity for Postpartum Family Planning Utilization</brief_title>
  <official_title>Enhancing Postpartum Family Planning Utilization Through Integration With Expanded Program for Immunization in Sidama, South Ethiopia: A Quasi Experimental Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hawassa University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hawassa University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to enhance postpartum family planning by integrating family planning&#xD;
      information with infant immunization services, which is the most widely utilized health&#xD;
      services globally.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study, a before-and-after type of quasi-experimental study will be conducted in&#xD;
      purposely selected health centers Sidama region, Ethiopia. base line assessment of postpartum&#xD;
      contraceptive utilization rate will be done which will be followed by an intervention. The&#xD;
      intervention consists of screening, counseling for family planning and referring mothers&#xD;
      coming for infant immunization services to family planning units. All mothers coming for&#xD;
      infant immunization service will be screened for and counseled for family planning and those&#xD;
      who will be voluntary to take any method will be referred to family planning unit. All&#xD;
      mothers who will not be voluntary will be re-counseled by the next visit.&#xD;
&#xD;
      Finally, the effect of this intervention on postpartum contraceptive utilization rate will be&#xD;
      reassessed. The expected outcome will be to see an improved contraceptive uptake during the&#xD;
      first year after delivery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 1, 2020</start_date>
  <completion_date type="Anticipated">March 17, 2021</completion_date>
  <primary_completion_date type="Actual">August 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>After the initiation of the intervention, improved Contraceptive prevalence rate will be expected as an outcome</measure>
    <time_frame>the outcome is measured two months after the initiation of the intervention</time_frame>
    <description>After counseling of the postpartum mothers for family planning, their informed decision making capacity to use contraceptives will be increased.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1474</enrollment>
  <condition>Contraceptive Usage</condition>
  <arm_group>
    <arm_group_label>Pre-intervention group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Pre-intervention group: women participated during the base line assessment will be labeled as Pre-intervention group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>postintervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Postintervention group: women participated after the intervention was initiated will be labeled as postintervention group.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>counseling</intervention_name>
    <description>Mothers presented to infant immunization units are going to be counseled for family planning services and if decide to take any method, they will be linked to family planning services</description>
    <arm_group_label>postintervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  all women visiting health facilities for infant immunization for at least two times&#xD;
             will be included.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are in difficulty of communicating during the study period will be excluded.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Abebaw Muluneh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hawassa University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sidama regional health bureau</name>
      <address>
        <city>Hawassa</city>
        <state>Sidama</state>
        <country>Ethiopia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ethiopia</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>January 30, 2021</study_first_submitted>
  <study_first_submitted_qc>March 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 3, 2021</study_first_posted>
  <last_update_submitted>March 1, 2021</last_update_submitted>
  <last_update_submitted_qc>March 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hawassa University</investigator_affiliation>
    <investigator_full_name>Abebaw Abeje Muluneh</investigator_full_name>
    <investigator_title>Mr.</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

